BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu J, Sun X. Complement system and age-related macular degeneration: drugs and challenges. Drug Des Devel Ther 2019;13:2413-25. [PMID: 31409975 DOI: 10.2147/DDDT.S206355] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Moskalev A, Stambler I, Caruso C. Innate and Adaptive Immunity in Aging and Longevity: The Foundation of Resilience. Aging Dis 2020;11:1363-73. [PMID: 33269094 DOI: 10.14336/AD.2020.0603] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kim J, Won JY. Effect of Photobiomodulation in Suppression of Oxidative Stress on Retinal Pigment Epithelium. Int J Mol Sci 2022;23:6413. [PMID: 35742861 DOI: 10.3390/ijms23126413] [Reference Citation Analysis]
3 Christopoulos PF, Gjølberg TT, Krüger S, Haraldsen G, Andersen JT, Sundlisæter E. Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases. Front Immunol 2021;12:668207. [PMID: 33912195 DOI: 10.3389/fimmu.2021.668207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Cao Y, Li XY, Tchivelekete GM, Li X, Zhou X, He Z, Reilly J, Tan Z, Shu X. Bioinformatical and biochemical analyses on the protective role of traditional Chinese medicine against age-related macular degeneration. Curr Eye Res 2022;:1-35. [PMID: 35947018 DOI: 10.1080/02713683.2022.2108456] [Reference Citation Analysis]
5 Feng L, Nie K, Huang Q, Fan W. Complement factor H deficiency combined with smoking promotes retinal degeneration in a novel mouse model. Exp Biol Med (Maywood) 2021;:15353702211052245. [PMID: 34775843 DOI: 10.1177/15353702211052245] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hanna RM, Henriksen K, Kalantar-Zadeh K, Ferrey A, Burwick R, Jhaveri KD. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers. Adv Chronic Kidney Dis 2022;29:149-160.e1. [PMID: 35817522 DOI: 10.1053/j.ackd.2021.11.006] [Reference Citation Analysis]
7 Jensen EG, Jakobsen TS, Thiel S, Askou AL, Corydon TJ. Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration. Int J Mol Sci 2020;21:E9752. [PMID: 33371261 DOI: 10.3390/ijms21249752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Telegina DV, Kozhevnikova OS, Antonenko AK, Kolosova NG. Features of Retinal Neurogenesis as a Key Factor of Age-Related Neurodegeneration: Myth or Reality? Int J Mol Sci 2021;22:7373. [PMID: 34298993 DOI: 10.3390/ijms22147373] [Reference Citation Analysis]
9 Sridevi Gurubaran I, Heloterä H, Marry S, Koskela A, Hyttinen JMT, Paterno JJ, Urtti A, Chen M, Xu H, Kauppinen A, Kaarniranta K. Oxidative Stress and Mitochondrial Damage in Dry Age-Related Macular Degeneration Like NFE2L2/PGC-1α -/- Mouse Model Evoke Complement Component C5a Independent of C3. Biology (Basel) 2021;10:622. [PMID: 34356477 DOI: 10.3390/biology10070622] [Reference Citation Analysis]
10 Somasundaran S, Constable IJ, Mellough CB, Carvalho LS. Retinal pigment epithelium and age-related macular degeneration: A review of major disease mechanisms. Clin Exp Ophthalmol 2020;48:1043-56. [PMID: 32710488 DOI: 10.1111/ceo.13834] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
11 Arrigo A, Bandello F. Molecular Features of Classic Retinal Drugs, Retinal Therapeutic Targets and Emerging Treatments. Pharmaceutics 2021;13:1102. [PMID: 34371793 DOI: 10.3390/pharmaceutics13071102] [Reference Citation Analysis]
12 Testa CM. Antisense Oligonucleotide Therapeutics for Neurodegenerative Disorders. Curr Geri Rep. [DOI: 10.1007/s13670-020-00341-7] [Reference Citation Analysis]
13 Park YG, Park YS, Kim IB. Complement System and Potential Therapeutics in Age-Related Macular Degeneration. Int J Mol Sci 2021;22:6851. [PMID: 34202223 DOI: 10.3390/ijms22136851] [Reference Citation Analysis]
14 Garred P, Tenner AJ, Mollnes TE. Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics. Pharmacol Rev 2021;73:792-827. [PMID: 33687995 DOI: 10.1124/pharmrev.120.000072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
15 Lee KS, Lin S, Copland DA, Dick AD, Liu J. Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration. J Neuroinflammation 2021;18:32. [PMID: 33482879 DOI: 10.1186/s12974-021-02088-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
16 Kim J, Park JY, Kong JS, Lee H, Won JY, Cho DW. Development of 3D Printed Bruch's Membrane-Mimetic Substance for the Maturation of Retinal Pigment Epithelial Cells. Int J Mol Sci 2021;22:1095. [PMID: 33499245 DOI: 10.3390/ijms22031095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Spaide RF. Treatment of Sorsby fundus dystrophy with anti-tumor necrosis factor-alpha medication. Eye (Lond) 2021. [PMID: 34376817 DOI: 10.1038/s41433-021-01735-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Balatsoukas DD, Tsaousis KT, Boboridis KG, Konstas AG, Topouzis F. Emerging Treatment Modalities for Neovascular Age-Related Macular Degeneration: A Systematic Overview. Adv Ther 2022;39:5-32. [PMID: 34724151 DOI: 10.1007/s12325-021-01949-7] [Reference Citation Analysis]
19 Lombardo M, Serrao S, Lombardo G. Challenges in Age-Related Macular Degeneration: From Risk Factors to Novel Diagnostics and Prevention Strategies. Front Med 2022;9:887104. [DOI: 10.3389/fmed.2022.887104] [Reference Citation Analysis]
20 Yang S, Li T, Jia H, Gao M, Li Y, Wan X, Huang Z, Li M, Zhai Y, Li X, Yang X, Wang T, Liang J, Gu Q, Luo X, Qian L, Lu S, Liu J, Song Y, Wang F, Sun X, Yu D. Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy. Sci Transl Med 2022;14:eabj2177. [PMID: 35648811 DOI: 10.1126/scitranslmed.abj2177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yu Q, Zhu J, Yao Y, Sun C. Complement family member CFI polymorphisms and AMD susceptibility from a comprehensive analysis. Biosci Rep 2020;40:BSR20200406. [PMID: 32215612 DOI: 10.1042/BSR20200406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Kubicka-trząska A, Żuber-łaskawiec K, Dziedzina S, Sanak M, Romanowska-dixon B, Karska-basta I. Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration. Medicina 2022;58:658. [DOI: 10.3390/medicina58050658] [Reference Citation Analysis]
23 Cerniauskas E, Kurzawa-Akanbi M, Xie L, Hallam D, Moya-Molina M, White K, Steel D, Doherty M, Whitfield P, Al-Aama J, Armstrong L, Kavanagh D, Lambris JD, Korolchuk VI, Harris C, Lako M. Complement modulation reverses pathology in Y402H-retinal pigment epithelium cell model of age-related macular degeneration by restoring lysosomal function. Stem Cells Transl Med 2020;9:1585-603. [PMID: 32815311 DOI: 10.1002/sctm.20-0211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
24 Qin S, Dong N, Yang M, Wang J, Feng X, Wang Y. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option. J Immunol Res 2021;2021:9945725. [PMID: 34368372 DOI: 10.1155/2021/9945725] [Reference Citation Analysis]
25 Kim J, Kong JS, Kim H, Han W, Won JY, Cho DW. Maturation and Protection Effect of Retinal Tissue-Derived Bioink for 3D Cell Printing Technology. Pharmaceutics 2021;13:934. [PMID: 34201702 DOI: 10.3390/pharmaceutics13070934] [Reference Citation Analysis]
26 Xiong Z, Wang Q, Li W, Huang L, Zhang J, Zhu J, Xie B, Wang S, Kuang H, Lin X, Lee C, Kumar A, Li X. Platelet-Derived Growth Factor-D Activates Complement System to Propagate Macrophage Polarization and Neovascularization. Front Cell Dev Biol 2021;9:686886. [PMID: 34150781 DOI: 10.3389/fcell.2021.686886] [Reference Citation Analysis]
27 Zeng Y, Yin X, Chen C, Xing Y. Identification of Diagnostic Biomarkers and Their Correlation with Immune Infiltration in Age-Related Macular Degeneration. Diagnostics (Basel) 2021;11:1079. [PMID: 34204836 DOI: 10.3390/diagnostics11061079] [Reference Citation Analysis]
28 Xiao J, Xie B, Dao D, Spedale M, D’souza M, Theriault B, Hariprasad SM, Sulakhe D, Chang EB, Skondra D. High-Fat Diet Alters the Retinal Pigment Epithelium and Choroidal Transcriptome in the Absence of Gut Microbiota. Cells 2022;11:2076. [DOI: 10.3390/cells11132076] [Reference Citation Analysis]
29 Navneet S, Rohrer B. Elastin turnover in ocular diseases: A special focus on age-related macular degeneration. Experimental Eye Research 2022. [DOI: 10.1016/j.exer.2022.109164] [Reference Citation Analysis]
30 Zauhar R, Biber J, Jabri Y, Kim M, Hu J, Kaplan L, Pfaller AM, Schäfer N, Enzmann V, Schlötzer-schrehardt U, Straub T, Hauck SM, Gamlin PD, Mcferrin MB, Messinger J, Strang CE, Curcio CA, Dana N, Pauly D, Grosche A, Li M, Stambolian D. As in Real Estate, Location Matters: Cellular Expression of Complement Varies Between Macular and Peripheral Regions of the Retina and Supporting Tissues. Front Immunol 2022;13:895519. [DOI: 10.3389/fimmu.2022.895519] [Reference Citation Analysis]
31 Nguyen QD, Heier JS, Do DV, Mirando AC, Pandey NB, Sheng H, Heah T. The Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye. Int J Retina Vitreous 2020;6:48. [PMID: 33072401 DOI: 10.1186/s40942-020-00250-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]